Stocks to Watch: FedEx, Kezar Life Sciences, Transcat
By Ben Glickman
FedEx said fiscal first-quarter profit rose from a year earlier and topped analysts' estimates. The shipping company's ongoing cost-cutting measures boosted margins, even as demand slipped. Shares rise 5.5% to $264.28 after hours.
Kezar Life Sciences agreed to allow Everest Medicines, a biopharmaceutical company, to develop and commercialize zetomipzomib in Greater China, South Korea and Southeast Asia. Under the agreement, Kezar may receive up to $132.5 million in total payments, plus tiered royalties. Shares rise 16% to $1.32 after hours.
Transcat said it would launch a public offering of its common stock. The industrial instruments maker didn't say how many shares it would sell, but noted it would use the proceeds to repay its credit facility, for working capital and for general corporate purposes. Shares sink 8.4% to $99.50 after hours.
Write to Ben Glickman at ben.glickman@wsj.com
(END) Dow Jones Newswires
September 20, 2023 20:15 ET (00:15 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
What’s Happening in the Markets This Week
-
4 Top Dividend-Paying REIT Stock Picks
-
After Earnings, Is Netflix Stock a Buy, a Sell, or Fairly Valued?
-
P-CAPE: A Better Way for Investors to Estimate Future Returns
-
Which Stocks Have Driven the Stealth Large-Value Rally?
-
Forecasts for Q2 GDP Report Show a Healthy but Slowing Economy
-
5 Stocks to Buy as the Market Rally Broadens
-
4 Top US Travel Stock Picks
-
How Do Interest Rates Affect Stock Market Returns?
-
American Airlines Earnings: Ticket Distribution Misstep Affected Results
-
Going Into Earnings, Is Albemarle Stock a Buy, a Sell, or Fairly Valued?
-
3 Top Cybersecurity Stock Picks for Long-Term Investors
-
AbbVie Earnings: Firm Sees Strong Next-Generation Immunology Drugs Sales
-
Ford Earnings: Warranty Problems on Older Vehicles Slam Results
-
ServiceNow Earnings: Operating on a Higher Plane Within Enterprise Software